Philippines: Second Health System Enhancement to Address and Limit COVID-19 under the Asia Pacific Vaccine Access Facility - Additional Financing

Sovereign Project | 54171-004

The additional financing of the Second Health System Enhancement to Address and Limit

COVID-19 under the Asia Pacific Vaccine Access Facility (HEAL2-AF) builds on the original

project and will expand the Philippines procurement and deployment of coronavirus disease

(COVID-19) vaccines. It will support the governments procurement of at least 40 million additional

doses of COVID-19 vaccines for eligible children, and third and booster shots for the wider

population.2 The HEAL2-AF complements the Asian Development Bank (ADB) Health System

Enhancement to Address and Limit COVID-19 (HEAL) project, which supports the government's

COVID-19 response.

Project Details

  • Project Officer
    Tanaka, Sakiko
    Southeast Asia Department
    Request for information
  • Approval Date
    13 December 2021
  • Country/Economy
    Philippines
  • Sector
    • Health

Related Projects

Project Name Second Health System Enhancement to Address and Limit COVID-19 under the Asia Pacific Vaccine Access Facility - Additional Financing
Project Number 54171-004
Country / Economy Philippines
Project Status Approved
Project Type / Modality of Assistance Loan
Source of Funding / Amount
Loan 4163-PHI: Second Health System Enhancement to Address and Limit COVID-19 under the Asia Pacific Vaccine Access Facility - Additional Financing
Ordinary capital resources US$ 250.00 million
Loan 8413-PHI: Second Health System Enhancement to Address and Limit COVID-19 under the Asia Pacific Vaccine Access Facility - Additional Financing
Asian Infrastructure Investment Bank US$ 250.00 million
Strategic Agendas Inclusive economic growth
Regional integration
Drivers of Change Gender Equity and Mainstreaming
Partnerships
Sector / Subsector

Health / Disease control of communicable disease
Gender Equity and Mainstreaming Effective gender mainstreaming
Description

The additional financing of the Second Health System Enhancement to Address and Limit

COVID-19 under the Asia Pacific Vaccine Access Facility (HEAL2-AF) builds on the original

project and will expand the Philippines procurement and deployment of coronavirus disease

(COVID-19) vaccines. It will support the governments procurement of at least 40 million additional

doses of COVID-19 vaccines for eligible children, and third and booster shots for the wider

population.2 The HEAL2-AF complements the Asian Development Bank (ADB) Health System

Enhancement to Address and Limit COVID-19 (HEAL) project, which supports the government's

COVID-19 response.
Project Rationale and Linkage to Country/Regional Strategy

On 11 March 2021, ADB approved a regular loan of $400 million for HEAL2 to be financed

from its ordinary capital resources.4 HEAL2 is cofinanced by AIIB with a loan of $300 million,

partially administered by ADB. HEAL2 provided the Government of the Philippines with timely

financing for procurement of safe and effective vaccines and related logistics, based on an agreed

list of eligible expenditures. In total, with a major change in scope of HEAL (footnote 3), ADB has

provided $425 million for COVID-19 vaccine procurement and deployment.
Impact

Health system performance in addressing public health outbreaks improved;

Protection of the public and reduction of COVID-19-related morbidity and mortality fostered; and

Economic growth and citizens' confidence restored
Project Outcome
Description of Outcome Priority populations vaccinated against COVID-19.
Progress Toward Outcome
Implementation Progress
Description of Project Outputs COVID-19 vaccines efficiently and effectively delivered.
Status of Implementation Progress (Outputs, Activities, and Issues)
Geographical Location Nation-wide
Safeguard Categories
Environment C
Involuntary Resettlement C
Indigenous Peoples C
Summary of Environmental and Social Aspects
Environmental Aspects
Involuntary Resettlement
Indigenous Peoples
Stakeholder Communication, Participation, and Consultation
During Project Design
During Project Implementation
Responsible ADB Officer Tanaka, Sakiko
Responsible ADB Department Southeast Asia Department
Responsible ADB Division Human and Social Development Division, SERD
Executing Agencies
Department of Health
Dr. Edilberto Fernandez
[email protected]
Tayuman Street
Sta. Cruz, Manila
Philippines
Timetable
Concept Clearance -
Fact Finding 21 Sep 2021 to 24 Sep 2021
MRM 22 Oct 2021
Approval 13 Dec 2021
Last Review Mission -
Last PDS Update 13 Dec 2021

Loan 4163-PHI

Milestones
Approval Signing Date Effectivity Date Closing
Original Revised Actual
13 Dec 2021 14 Dec 2021 27 Dec 2021 30 Sep 2024 - -
Financing Plan Loan Utilization
Total (Amount in US$ million) Date ADB Others Net Percentage
Project Cost 299.37 Cumulative Contract Awards
ADB 250.00 01 Feb 2022 0.00 0.00 0%
Counterpart 49.37 Cumulative Disbursements
Cofinancing 0.00 01 Feb 2022 0.00 0.00 0%

Loan 8413-PHI

Financing Plan Loan Utilization
Total (Amount in US$ million) Date ADB Others Net Percentage
Project Cost 250.00 Cumulative Contract Awards
ADB 0.00 - 0.00 0.00 %
Counterpart 0.00 Cumulative Disbursements
Cofinancing 250.00 - 0.00 0.00 %

Project Data Sheets (PDS) contain summary information on the project or program. Because the PDS is a work in progress, some information may not be included in its initial version but will be added as it becomes available. Information about proposed projects is tentative and indicative.

The Access to Information Policy (AIP) recognizes that transparency and accountability are essential to development effectiveness. It establishes the disclosure requirements for documents and information ADB produces or requires to be produced.

The Accountability Mechanism provides a forum where people adversely affected by ADB-assisted projects can voice and seek solutions to their problems and report alleged noncompliance of ADB's operational policies and procedures.

In preparing any country program or strategy, financing any project, or by making any designation of, or reference to, a particular territory or geographic area in this document, the Asian Development Bank does not intend to make any judgments as to the legal or other status of any territory or area.

Title Document Type Document Date
Loan Agreement (Ordinary Operations) for Loan 4163-PHI: Second Health System Enhancement to Address and Limit COVID-19 under the Asia Pacific Vaccine Access Facility - Additional Financing Loan Agreement (Ordinary Resources) Dec 2021
Second Health System Enhancement to Address and Limit COVID-19 under the Asia Pacific Vaccine Access Facility - Additional Financing: Report and Recommendation of the President Reports and Recommendations of the President Nov 2021
Second Health System Enhancement to Address and Limit COVID-19 under the Asia Pacific Vaccine Access Facility - Additional Financing: Project Administration Manual Project/Program Administration Manual Nov 2021
Second Health System Enhancement to Address and Limit COVID-19 under the Asia Pacific Vaccine Access Facility - Additional Financing: Procurement Plan Procurement Plans Nov 2021

Safeguard Documents See also: Safeguards
Safeguard documents provided at the time of project/facility approval may also be found in the list of linked documents provided with the Report and Recommendation of the President.

None currently available.

Evaluation Documents See also: Independent Evaluation

None currently available.

Related Publications

None currently available.

The Access to Information Policy (AIP) establishes the disclosure requirements for documents and information ADB produces or requires to be produced in its operations to facilitate stakeholder participation in ADB's decision-making. For more information, refer to the Safeguard Policy Statement, Operations Manual F1, and Operations Manual L3.

Requests for information may also be directed to the InfoUnit.

Tenders

No tenders for this project were found.

Contracts Awarded

No contracts awarded for this project were found